The U.S. Food and Drug Administration (FDA) recently issued a warning to Nutra Pharma Corp. for illegally marketing multiple products with fraudulent claims, as detailed in a news release published on the FDA website. These products were portrayed as being able to treat addiction, chronic pain, and a series of other conditions. FDA Commissioner Scott Gottlieb, M.D. expressed the FDA’s concerns regarding the fraudulent marketing, stating, “We’re especially focused on those who would exploit Americans harmed by the opioid crisis with the false promise of products that can treat pain or addiction, but that offer no such benefit.”
The news release continues to explain the FDA’s goal of increasing the availability of medication assisted treatment for individuals with opioid addictions:
“The FDA is taking steps to make safe and effective MAT available to those who suffer from OUD and to reduce the stigma that is sometimes associated with use of these therapies. Using products with unsubstantiated claims may prevent those addicted to opioids from seeking approved treatments that have been demonstrated to be safe and effective, delay their path to recovery and put them at greater risk of death.”
Read the full news release here.
Find doctors and treatment centers specializing in medically assisted treatment through our directory.